go-v.orgdoi

Analysis of Risk Factors for Early Progression of Prostate Cancer After Initial Endocrine Therapy

Bowen Hu, Feng Shu, Yan Liu, Jiaying Zhu, Haojie Wang, Nengqing Xie, Xiaoling Liu, Guanmin Jiang, Minbo Yan, Yingbo Dai · Journal of Cancer · 2023

  • DOI 10.7150/jca.81513
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2023

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2023

Abstract

Background: Prolonged androgen deprivation therapy (ADT) in patients with prostate cancer can eventually lead to the development of castration-resistant prostate cancer (CRPC).Once CRPC occurs, the patient's prognosis will be inferior.However, the risk factors for progression to CRPC in a short period of time are unclear.Methods: We retrospectively analyzed prostate cancer patients who received their first ADT between January 1, 2015 and January 1, 2021.The main statistical methods used were a logistic regression model and Kaplan-Meier survival analysis.Results: Among 159 prostate cancer patients initially treated with ADT, 90 were screened for inclusion.Patients who progressed to CRPC after ADT were included in group B and others were included in group A.

Group B was divided into group B1 and B2 according to whether CRPC progressed within 18 months.Multi-factor logistic regression analysis showed that the time to PSA nadir (TTN) (p = 0.031) and serum lactate dehydrogenase (LDH) (p = 0.013) were significantly different between Group A and B.

TTN (p < 0.001), LDH (p = 0.001) and platelet to lymphocyte ratio (PLR) (p = 0.005) were significantly different between Group B1 and B2.Kaplan-Meier survival analysis and log-rank tests showed that TTN, LDH, and PLR statistically differed in CRPC patients' progression-free survival.The ROC curve showed the AUC value of TTN combined with PLR and LDH increased to 0.958 (95% CI 0.911-0.997,p < 0.001).The Chi-square test showed that the expression of p63 in group A was higher than that in groups B1 (p = 0.002) and B2 (p = 0.001).Conclusion: Lower TTN, higher LDH and PLR were associated with early CRPC occurrence after ADT in hormone-sensitive prostate cancer patients.p63 expression was associated with favorable prognosis in prostate cancer patients.

Open the resolved locator · 10.7150/jca.81513

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:51 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v14p0519.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.